AzTrials
AzTrials

AnisomeliaNCT04235517

RSA Study on the Behaviour of the Growth Plate During and After Temporary Hemi-epiphysiodesis and Epiphysiodesis

An observational study of Anisomelia and Deformity of Limb, run by Oslo University Hospital at 1 site in Norway.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

By using radiostereometric analysis (RSA) we will be able to study growth during and after temporary epiphysiodesis and with great accuracy be able to detect asymmetric growth following this procedure. Read more about this study

Who is it for?
Ages 3 to 16 years
Conditions the study is for
Anisomelia, Deformity of Limb
What is being tested?
Temporary hemi-epiphysiodesis or epiphysiodesis
How many people
10 participants
Where
1 siteNorway
Study dates
Jan 2017to Jan 2027
How long will I take part?
5 Years
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 16 years
  • All sexes
  • Child

Study population: Children with growth remaining and limb length discrepancy or axial deviations in the lower extremity

Who may be able to join

  • Children with idiopathic axial deviations in the lower extremities
  • Children with limb length discrepancys where timing of epiphysiodesis is difficult because of a big discrepancy in skeletal age and chronological age

Who cannot join

  • Children with axial deviations and pathological physis

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Anne B Breen, MD contact

92226905 ext. +47

anneb3@ous-hf.no

Joachim Horn, MD,PHD contact

48047706 ext. +47

jhorn@ous-hf.no

Norway1 site, 1 recruiting
  • The Ortopedic dep at Oslo Unversity Hospital, Rikshospitalet

    Oslo, 0424

    Anne B Breen, MD, 92226905 ext. +47, anneb3@ous-hf.no

    Recruiting

Other trials in Norway

About this study

Official title: Behaviour of the Growth Plate in Patients Operated With Either Permanent or Temporary Hemi-epiphysiodesis or Epiphysiodesis Through by the Use of Radiostereometric Analysis (RSA)

By using radiostereometric analysis (RSA) we will be able to study growth during and after temporary epiphysiodesis and with great accuracy be able to detect asymmetric growth following this procedure.

By using the same method we also want to analyse patients with axial deviations operated with guided growth (tension band plating) to study the growth during and after the procedure and be able to set the correct timing for removal of the implant.

Read the detailed description

The RSA method consists of implantation of small tantalum beads on either side of the physis during surgery on the the physis. Later analysis of the RSA Pictures with the RSA-method will give us an microscopically accurate measure of the growth in three planes.

Being tested
Temporary hemi-epiphysiodesis or epiphysiodesis
Keywords
LLD, guided growth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Temporary hemi-epiphysiodesis or epiphysiodesisOther

    Tension band plate (eight-plate, pedi plate), staple or locking plate

Study groups in NCT04235517
Study groupRoleWhat they receive
Axial deviations in childrenChildren with axial deviations in the lower extremity treated with guided growth
Receives: Other: Temporary hemi-epiphysiodesis or epiphysiodesis
Limb length discrepancy in childrenChildren with limb length discrepancy treated with temporary epiphysiodesis
Receives: Other: Temporary hemi-epiphysiodesis or epiphysiodesis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Behaviour of the growth plate during and after temporary hemi-epiphysiodesis and epiphysiodesis

    Radiostereometric analysis of growth

    Measured: 4 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jan 2020
  2. Study startJan 2017
  3. Primary completionJan 2027 (estimated)
  4. Study completionJan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
10 participants (estimated)
Target duration
5 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT04235517
Sponsor's protocol ID
18/02287
Status last verified
Sep 2025
First submitted
16 Jan 2020
Last updated
4 Sep 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Anisomelia and Deformity of Limb, run by Oslo University Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 4 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Anne B Breen, MD (92226905 ext. +47, anneb3@ous-hf.no), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Behaviour of the growth plate during and after temporary hemi-epiphysiodesis and epiphysiodesis (time frame: 4 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in